ProclaimRx & Google DeepMind Lead AI Innovations in Cancer Therapy - Life AI Weekly #39

Hi there,

Welcome to this week's edition of Life AI Weekly, where we delve into the latest advancements in healthcare and life sciences AI. This week, we highlight significant developments such as ProclaimRx launching a new AI platform aimed at enhancing decision-making in the pharmaceutical industry. Meanwhile, Google DeepMind has identified a key molecule that could play a crucial role in cancer therapy, showcasing the potential of AI in medical research.

In other news, Caltech has developed NucleusDiff AI, a tool designed to aid in drug design, while iOncologi has secured a U.S. patent for its RNA-based cancer therapy. These stories, among others, underscore the transformative impact of AI technologies in healthcare, offering new possibilities for treatment and research. Stay tuned as we explore these exciting developments and more in this edition.

C2A Security has acquired Vigilant Ops to enhance AI-driven product security in the MedTech industry. Meanwhile, CoMind has secured $102.5 million in Series A funding to expand its AI-driven brain monitoring system, with the investment led by Plural.

ProclaimRx has launched an AI platform designed to transform complex pharmaceutical data into actionable insights, enhancing decision-making for commercial teams. Meanwhile, Google DeepMind has identified Silmitasertib (CX-4945) as a key molecule that may enhance antigen presentation in cancer treatment, potentially aiding in transforming 'cold tumors' into 'hot' ones.

Google and Yale University have developed the AI model C2S-Scale 27B to enhance cancer immunotherapy research by analyzing single cells.
Alethios launched an AI-driven platform on October 21, 2025, to improve accessibility in health research, featuring the Alethios Study Planner for efficient study design.

iOncologi has secured a U.S. patent for its RNA-based cancer therapy aimed at boosting immune checkpoint inhibitors. 10x Genomics and Anthropic have partnered to integrate single cell and spatial analysis tools into Claude for Life Sciences. Astraveus has appointed Didier Masson as COO and Ken Kotz as CTO to advance AI-driven cell therapy manufacturing. Benchling and Anthropic are collaborating to enhance AI applications in biotech research and development. Breakthrough Genomics unveiled new AI capabilities at ASHG 2025, featuring the Virtual Geneticist® platform. Google Research introduced DeepSomatic, an AI tool for improved tumor genetic analysis.

Health Data Analytics Institute (HDAI) launched new AI tools at HLTH 2025 to improve healthcare outcomes by predicting patient risks and summarizing medical records.
Cedar introduced Cedar Cover on October 20, 2025, a digital tool to assist hospitals in managing Medicaid coverage and financial aid for underinsured and uninsured patients.